Yujiao Zhang

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2023
Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.

Yujiao Zhang, Xizhi Liu, Wenhui Dang

|Nov 06, 2020
Corrigendum: Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling.

Anqi Luo, Min Meng, Guanying Wang

|Sep 25, 2020
The requirement for cyclin E in c-Myc overexpressing breast cancers.

Yu Zhou, Yan Geng, Yujiao Zhang

|May 13, 2020
Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling.

Anqi Luo, Min Meng, Guanying Wang

|Sep 28, 2018
Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.

Yujiao Zhang, Yizeng Fan, Shangke Huang

Pageof 1

Frequent Collaborators

2 joint publications

Anqi Luo

2 joint publications

Min Meng

2 joint publications

Guanying Wang

2 joint publications

Rui Han